10-K: Plexus Corp. Reports Fiscal Year 2024 Results Amidst Market Headwinds

Plexus Corp. experienced a decrease in net sales and operating income for fiscal year 2024, influenced by market-driven inventory corrections and weaker demand in key sectors.

Summary

• Plexus Corp.'s net sales for fiscal year 2024 decreased by 5.9% to $3.96 billion, compared to $4.21 billion in fiscal year 2023.
• The company's gross profit also saw a decrease of 4.1%, totaling $378.5 million, with a gross margin of 9.6%.
• Operating income for fiscal year 2024 was $167.7 million, a 14.4% decrease from the previous year, with an operating margin of 4.2%.
• Net income for fiscal year 2024 decreased by 19.6% to $111.8 million, and diluted earnings per share fell to $4.01.
• The company's return on invested capital (ROIC) was 11.8%, resulting in an economic return of 3.6%, based on a weighted average cost of capital (WACC) of 8.2%.
• Cash flow from operations was $436.5 million, a significant increase from $165.8 million in the prior year, primarily due to inventory reduction efforts.
• Free cash flow for fiscal year 2024 was $341.3 million, compared to $61.8 million in fiscal year 2023.
• The company repurchased 165,733 shares of its common stock for $19.6 million during the three months ended September 28, 2024.
• The company's cash and cash equivalents and restricted cash were $347.5 million as of September 28, 2024, while debt, finance lease and other financing obligations were $247 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive aspects like strong cash flow and share repurchases, but the overall tone is negative due to decreased sales, income, and earnings. The company also faces significant risks and challenges.

Positives

• The company's cash flow from operations significantly increased year-over-year.
• Free cash flow saw a substantial increase compared to the previous year.
• The company successfully reduced inventory levels.
• Plexus maintains a strong cash position with $347.5 million in cash and cash equivalents and restricted cash.
• The company continues to execute share repurchases.

Negatives

• Net sales decreased by 5.9% compared to the previous fiscal year.
• Operating income declined by 14.4% year-over-year.
• Net income decreased by 19.6% compared to the previous fiscal year.
• Diluted earnings per share decreased to $4.01.
• The company experienced market-driven inventory corrections and weaker demand in the Healthcare/Life Sciences and Industrial sectors.

Risks

• The company faces risks related to market-driven inventory corrections and weaker demand in the Healthcare/Life Sciences and Industrial sectors.
• The company is exposed to potential volatility in end-market demand due to external factors such as inflation, global conflicts, and economic uncertainty.
• The company is subject to risks associated with component shortages, delays, price fluctuations, and supplier quality concerns.
• The company is exposed to risks related to cybersecurity threats and data breaches.
• The company faces risks related to its complex business model and rapidly changing technology requirements.
• The company is subject to risks associated with operating in multiple countries, including adverse local developments and currency risks.
• The company is exposed to physical risks, including natural disasters and weather events caused by global climate change.
• The company faces risks related to potential liability claims arising from the products it designs, manufactures, or services.
• The company is subject to risks related to its workforce, including the inability to attract, develop, and retain personnel.
• The company is exposed to risks related to changes in tax laws and potential tax disputes.

Future Outlook

The company expects its annual effective tax rate for fiscal 2025 to be approximately 14.0% to 16.0%. Capital expenditures for fiscal 2025 are estimated to be between $120.0 million and $150.0 million.

Management Comments

• Management believes that the company's balance sheet is positioned to support potential future challenges presented by macroeconomic pressures.
• Management believes that the company's cash balance, together with cash available under its credit facility, will be sufficient to meet its liquidity needs and potential share repurchases for the next twelve months and for the foreseeable future.

Industry Context

The company operates in a highly competitive market, with a goal to be best-in-class at meeting the unique needs of its customers. The company competes with numerous providers with global operations, as well as those which operate on only a local or regional basis. The company also competes with in-house capabilities of current and potential customers.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• The document does mention that the company's net promoter score is industry leading.
• The document notes that the company's cost variance from competitors is especially evident relative to those that provide electronics manufacturing services for high-volume, less complex products, with less stringent requirements (e.g., consumer electronics).

Legal Proceedings

• The company is party to lawsuits in the ordinary course of business.
• The company recorded a one-time, non-recurring payment of $15.8 million related to an arbitration decision in Norway during fiscal 2023, and received $2.3 million of additional insurance proceeds related to this decision during fiscal 2024.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales, operating income, and net income.
• Employees may be affected by potential workforce reductions and changes in compensation.
• Customers may be impacted by potential supply chain disruptions and changes in pricing.
• Suppliers may be affected by changes in demand and potential price fluctuations.
• Creditors may be impacted by changes in the company's financial performance and ability to repay debt.

Next Steps

• The company will continue to monitor market conditions and adjust its strategies as needed.
• The company will continue to focus on managing its working capital and inventory levels.
• The company will continue to invest in new technologies and capabilities to remain competitive.
• The company will continue to evaluate potential uses of excess cash, which may include additional share repurchases, a special dividend, or recurring dividends.

Key Dates

Keywords

electronics manufacturing services, supply chain, manufacturing, aerospace, defense, healthcare, life sciences, industrial, financial results, component shortages, cybersecurity, sustainability, human capital, global operations